CENPK and urinary bladder carcinoma: Previous studies have suggested links between centromere protein K (CENPK) and the progression of malignant tumors, such as ovarian cancer, breast cancer, hepatocellular carcinoma, bladder cancer, oligodendrogliomas, and lung adenocarcinoma [9–14].